<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-J88ZV9GA</identifier><date>2011</date><creator>Gaberc-Porekar, Vladka</creator><creator>Maver, Tina</creator><creator>Milunović, Tatjana</creator><relation>documents/doc/J/URN_NBN_SI_doc-J88ZV9GA_001.htm</relation><relation>documents/doc/J/URN_NBN_SI_doc-J88ZV9GA_001.pdf</relation><relation>documents/doc/J/URN_NBN_SI_doc-J88ZV9GA_001.txt</relation><format format_type="issue">4</format><format format_type="volume">62</format><format format_type="type">article</format><format format_type="extent">str. 175-178</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">4928794</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-J88ZV9GA</identifier><language>eng</language><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">biološka zdravila</subject><subject language_type_id="slv">druga generacija terapevtskih proteinov</subject><subject language_type_id="slv">HESilacija</subject><subject language_type_id="eng">HESylation</subject><subject language_type_id="eng">PEG reagents</subject><subject language_type_id="slv">PEGilacija</subject><subject language_type_id="slv">PEGilacijski reagenti</subject><subject language_type_id="slv">PEGilirani proteini</subject><subject language_type_id="eng">PEGylated proteins</subject><subject language_type_id="eng">PEGylation</subject><subject language_type_id="eng">second-generation biopharmaceuticals</subject><title>Pregled druge generacije bioloških zdravil s poudarkom na PEGilaciji</title><title>Review of second-generation biopharmaceuticals with emphasis on PEGylation</title></Record>